Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
4
×
biotech
boston blog main
boston top stories
national blog main
national top stories
new york blog main
cancer
clinical trials
detroit blog main
detroit top stories
life sciences
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
technology
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adeno-associated virus
alex gibney
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
biology
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer immunotherapy
What
focus
4
×
key
regenerative
adding
ago
ahead
aiming
ambien
american
annual
asco
attendees
attention
attributes
balance
biopharmaceutical
biotech
build
called
camp’s
cancer
cash
celgene
cells
celularity
charm
chicago
city
clinical
combinations
community’s
company
creating
days
decibel
derived
diamandis
drug
drugs
emerged
Language
unset
Current search:
focus
×
startups
×
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
